Sanofi has joined a growing list of drugmakers going after alpha-synuclein targeting drugs for Parkinson's disease, licensing a bispecific antibody from South Korea's ABL Bio in a deal that could be ...

UK contract development and manufacturer organisation (CDMO) Oxford Biomedica confirmed this morning it is in talks that could result in the acquisition of rival ABL Europe from France’s Institut ...

The ABL90 FLEX PLUS delivers lab-quality results at the point of care for more confident treatment decisions. Continuous automatic quality management (AQM) provides automatic quality control, ...

JPalmer Collective (JPC) announced the appointment of Ellie Jester as Chief of Staff. Jester joins JPC at a time of continued growth, as the firm builds out its team ...